Skip to content
Search

Latest Stories

Seb James prescribes data sharing between NHS and community pharmacy for better health outcomes

Boots UK supremo Seb James has said better sharing of patient data between community pharmacy and the NHS could transform the way healthcare services are delivered in the country.

Speaking at a Digital Health Rewired event in London on Tuesday (14 March), he spoke of a recent study by Imperial College London which found that customer loyalty card data could be an early predictor of ovarian cancer.


The study tracked the spending of consenting Boots Advantage Card holders to investigate a link between a diagnosis of ovarian cancer and a pattern of buying over-the-counter pain and indigestion medications.

The managing director of Boots UK & ROI said: “Just as we can advise our customers which skincare product might be suitable for them – patient care should be personalised and seamless, offering complete continuity between hospital, GPs and the local pharmacy.

“Not only would this take critical strain out of the NHS system, but it would also crucially make it easier for patients to get access to the care and services they need. One way to help facilitate this is the better sharing of patient data between community pharmacy and the NHS. With patient consent, better data sharing could transform the way healthcare services are delivered.”

Diabetes screening

Boots is also planning to launch a new private pilot diabetes screening tests from May in seven stores across Manchester, London and Birmingham, cities with the most prevalence of diabetes case, with the possibility of spreading it across more stores next year.

James, who believes diabetes could be a particularly suitable area to benefit from greater data sharing between community pharmacy and the NHS, said that Boots could deliver these tests on behalf of the NHS and welcomes conversations with national and local service commissioners.

He said: “There are currently around 850,000 people living with undiagnosed diabetes and we want to help address that. As well as having community pharmacies like Boots perform screening tests, there could be an expanded role for diabetes management in community pharmacy.

"Our pharmacy team members could support with checks when patients collect their medicines and feed this information back to their GP via their patient record. That could be really powerful.”

James also revealed that Boots was extending its partnership with Our Future Health – a project that aims to create one of the most detailed pictures ever of people’s health to help transform the prevention, detection and treatment of diseases.

In a press release, Boots said since last year it has been raising awareness among its Advantage Card members to attract volunteers to take part in the initiative. During a pilot in 10 stores, Boots helped facilitate the recruitment of over 10,000 volunteers since last summer. The partnership which is now being extended to a further 10 stores this month will get another 70 stores to sign up by the end of the year.

Currently, community pharmacies in England do not have full read and write access to NHS patient health records.

More For You

RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less